Cloud DX Announces the Date of Its Second Quarter Investor Update and Earnings Call, Retention of Market Maker and Retention of IR Specialist

Cloud DX (TSXV:CDX)(OTCQB:CDXFF), (the 'Company') a leading North American provider of virtual care and remote patient monitoring solutions today announced that the Company will publish its operating results for the second quarter of 2021 on Monday August 16th, 2021

The Company will host a live webcast with Robert Kaul, Cloud DX CEO to review its progress to date and its fiscal second quarter results beginning at 1:30 pm Eastern time on Tuesday August 17^th, 2021.

Those who wish to participate in the webcast should register at: https://zoom.us/webinar/register/WN_aoM3X1mORRmEUTNpQ32RHQ

Cloud DX is also pleased to announce that, subject to regulatory approval, it has retained Generation IACP INC. (GIACP) to initiate its market making services to the Company and Mercova Capital (Evan Eadie) to perform Investor Relations services both in compliance with the policies and guidelines of the TSX Venture Exchange (the TSXV) and other applicable legislation. GIACP will trade shares of Cloud DX on the TSXV for the purposes of maintaining a reasonable market and improving the liquidity of Cloud DX's common shares and Mercova Capital (Evan Eadie) will provide an investor outreach program among other services.

The agreement between GIACP and the Company sees the Company paying GIACP $7,500 per month during the term, payable quarterly in advance. The engagement may be terminated by either party with 30 days written notice. The Company and GIACP act at arm's length but GIACP and/or its clients may have an interest, directly or indirectly, in the securities of Cloud DX. The agreement is principally for the purposes of maintaining market stability and liquidity for the Company's common shares and is not a formal market making agreement. There are no performance factors contained in the agreement between GIACP and the Company and GIACP will not receive any shares or options from the Company as compensation for services it will render. Ari Scheer will be the service provider, has decades of industry experience and is a designated marker and ultimately a market maintenance and liquidity provider.

The agreement between Evan Eadie (Mercova Capital) and the Company sees the Company paying Mercova Capital $3,500 per month during the term, payable monthly in arrears. The engagement may be terminated by either party with 30 days written notice. The Company and Mercova Capital act at arm's length but Mercova Capital and/or its clients may have an interest, directly or indirectly, in the securities of Cloud DX. The agreement is principally for the purpose of creating market awareness for the Company. Evan Eadie will be the service provider.

About Cloud DX
Accelerating virtual healthcare's future, Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company 'World Changing Idea' finalist and one of 'Canada's Ten Most Prominent Telehealth Providers.'

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links
Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/
Instagram https://www.instagram.com/cloud.dx/

For media inquiries, please contact:
Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries, please contact:
Jay Bedard
Investor Relations Manager
647-881-8418
jay.bedard@CloudDX.com

SOURCE: Cloud DX Inc.

View source version on accesswire.com:
https://www.accesswire.com/658247/Cloud-DX-Announces-the-Date-of-Its-Second-Quarter-Investor-Update-and-Earnings-Call-Retention-of-Market-Maker-and-Retention-of-IR-Specialist

News Provided by ACCESSWIRE via QuoteMedia

cloud dx tsxv:cdx emerging tech investing Emerging Tech Investing

SEC Reopens Investigation on Neuralink and Musk’s Twitter Deal

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant company, alongside a probe into Musk’s acquisition of Twitter, now rebranded as X.

A letter from Musk’s lawyer, Alex Spiro, disclosed the development on Thursday (December 12), raising questions about the ongoing legal disputes between Musk and the SEC, according to a Reuters report.

The letter, addressed to outgoing SEC Chair Gary Gensler, outlines the reopening of the Neuralink investigation and a settlement demand regarding the Twitter takeover, which happened in 2022.

Keep reading...Show less

Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to announce that it has more than doubled the acreage on the recently acquired George Lake South Antimony Project in New Brunswick, Canada. This project now consists of 4,722 contiguous acres prospective for antimony.

James Nelson, President of Spearmint, stated, "In light of the recent ban of antimony by China to the USA, we made this strategic acquisition increasing the size of the George Lake South Antimony Project. Management feels that antimony will be one of the most sought after resources in 2025 and we plan to pursue this space with vigor and are currently evaluating additional projects. Management is formulating a plan on the George Lake South Antimony Project, and management also intends to update the market on Spearmint's crypto diversification plan in the near future as well. These are truly exciting times for Spearmint and Spearmint shareholders."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Spearmint Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to provide an update to shareholders on the impact of the strike by the Canadian Union of Postal Workers on the Company's ability to comply with its obligations to deliver to shareholders its financial statements and related disclosure and proxy-related materials in respect of the Company's annual general meeting of shareholders (the "Meeting") scheduled to be held at Cozen O'Connor LLP - 550 Burrard Street, Suite 2501, Vancouver, B.C., on Thursday, Dec. 19, 2024, at 10 a.m. PST.

James Nelson, President of Spearmint stated, "We want all of our shareholders to be aware of the current situation as there are many exciting events occurring for Spearmint in the short and medium term."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

RETRANSMISSION: Spearmint Comments on China's Ban of Critical Mineral Exports to the USA, including Antimony

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to comment on yesterday's announcement of China banning exports of critical minerals including antimony to the United States. As trade tensions escalate between the USA and China, this move clearly emphasizes the urgent need for Western nations to secure reliable long-term sources of these critical minerals which are now at the forefront of the global supply chain crisis.

Antimony is an essential component in semi-conductors, battery storage technology, and has several military applications. Prices of antimony trioxide in Rotterdam had soared by 228% since the beginning of the year to $39,000 a metric ton on Nov. 28, data from information provider Argus showed⁽¹⁾. The move is a considerable escalation of tensions in supply chains where access to raw material units is already tight in the West⁽¹⁾.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

Gold Investing

Cloud DX Announces the Date of Its Second Quarter Investor Update and Earnings Call, Retention of Market Maker and Retention of IR Specialist

Musk's contentious history with the SEC

Deepening relationship between Musk and Trump

Latest News

Latest Press Releases

Related News

TOP STOCKS